|
1
|
Sherman M: Epidemiology of hepatocellular
carcinoma. Oncology. 78(Suppl 1): 7–10. 2010. View Article : Google Scholar
|
|
2
|
Tanaka M, Katayama F, Kato H, et al:
Hepatitis B and C virus infection and hepatocellular carcinoma in
China: a review of epidemiology and control measures. J Epidemiol.
21:401–416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li S, Li Y, Hu R, et al: The mTOR
inhibitor AZD8055 inhibits proliferation and glycolysis in cervical
cancer cells. Oncol Lett. 5:717–721. 2013.PubMed/NCBI
|
|
4
|
Chresta CM, Davies BR, Hickson I, et al:
AZD8055 is a potent, selective, and orally bioavailable
ATP-competitive mammalian target of rapamycin kinase inhibitor with
in vitro and in vivo antitumor activity. Cancer Res. 70:288–298.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holt SV, Logie A, Davies BR, et al:
Enhanced apoptosis and tumor growth suppression elicited by
combination of MEK (selumetinib) and mTOR kinase inhibitors
(AZD8055). Cancer Res. 72:1804–1813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levine B and Klionsky DJ: Development by
self-digestion: molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang S, Yang ZJ, Yu C and Sinicrope FA:
Inhibition of mTOR kinase by AZD8055 can antagonize
chemotherapy-induced cell death through autophagy induction and
down-regulation of p62/sequestosome 1. J Biol Chem.
286:40002–40012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sini P, James D, Chresta C and Guichard S:
Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase
inhibitor AZD8055 induces autophagy and cell death in cancer cells.
Autophagy. 6:553–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Willems L, Chapuis N, Puissant A, et al:
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor
activity in acute myeloid leukemia. Leukemia. 26:1195–1202. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang HL, Zheng WL, Zhao R, Zhang B and Ma
WL: FBXO31 is down-regulated and may function as a tumor suppressor
in hepatocellular carcinoma. Oncol Rep. 24:715–720. 2010.PubMed/NCBI
|
|
11
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B. 2001.
View Article : Google Scholar
|
|
12
|
Zhao R, Yan Q, Lv J, et al: CHD5, a tumor
suppressor that is epigenetically silenced in lung cancer. Lung
Cancer. 76:324–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aoki H, Kondo Y, Aldape K, et al:
Monitoring autophagy in glioblastoma with antibody against isoform
B of human microtubule-associated protein 1 light chain 3.
Autophagy. 4:467–475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsushita M, Suzuki NN, Obara K, Fujioka
Y, Ohsumi Y and Inagaki F: Structure of Atg5. Atg16, a complex
essential for autophagy. J Biol Chem. 282:6763–6772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pyo JO, Jang MH, Kwon YK, et al: Essential
roles of Atg5 and FADD in autophagic cell death: dissection of
autophagic cell death into vacuole formation and cell death. J Biol
Chem. 280:20722–20729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seglen PO and Gordon PB: 3-Methyladenine:
specific inhibitor of autophagic/lysosomal protein degradation in
isolated rat hepatocytes. Proc Natl Acad Sci USA. 79:1889–1892.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang CW and Klionsky DJ: The molecular
mechanism of autophagy. Mol Med. 9:65–76. 2003.
|
|
18
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bursch W, Hochegger K, Torok L, Marian B,
Ellinger A and Hermann RS: Autophagic and apoptotic types of
programmed cell death exhibit different fates of cytoskeletal
filaments. J Cell Sci. 113:1189–1198. 2000.PubMed/NCBI
|
|
20
|
Bursch W, Ellinger A, Gerner C, Frohwein U
and Schulte-Hermann R: Programmed cell death (PCD). Apoptosis,
autophagic PCD, or others? Ann NY Acad Sci. 926:1–12. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Le XF, Mao W, Lu Z, Carter BZ and Bast RC
Jr: Dasatinib induces autophagic cell death in human ovarian
cancer. Cancer. 116:4980–4990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiong HY, Guo XL, Bu XX, et al: Autophagic
cell death induced by 5-FU in Bax or PUMA deficient human colon
cancer cell. Cancer Lett. 288:68–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fruman DA and Edinger AL: Cancer therapy:
staying current with AMPK. Biochem J. 412:e3–e5. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji C, Yang B, Yang YL, et al: Exogenous
cell-permeable C6 ceramide sensitizes multiple cancer cell lines to
Doxorubicin-induced apoptosis by promoting AMPK activation and
mTORC1 inhibition. Oncogene. 29:6557–6568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yun SM, Jung JH, Jeong SJ, Sohn EJ, Kim B
and Kim SH: Tanshinone IIA induces autophagic cell death via
activation of AMPK and ERK and inhibition of mTOR and p70 S6K in
KBM-5 leukemia cells. Phytother Res. Jun 27–2013.(Epub ahead of
print). View
Article : Google Scholar
|
|
26
|
Puissant A, Robert G, Fenouille N, et al:
Resveratrol promotes autophagic cell death in chronic myelogenous
leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK
activation. Cancer Res. 70:1042–1052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chandrasekar B, Boylston WH, Venkatachalam
K, Webster NJ, Prabhu SD and Valente AJ: Adiponectin blocks
interleukin-18-mediated endothelial cell death via APPL1-dependent
AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN
suppression. J Biol Chem. 283:24889–24898. 2008.PubMed/NCBI
|
|
28
|
Lee JW, Park S, Takahashi Y and Wang HG:
The association of AMPK with ULK1 regulates autophagy. PLoS One.
5:e153942010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egan DF, Shackelford DB, Mihaylova MM, et
al: Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase
connects energy sensing to mitophagy. Science. 331:456–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
